Enlil Launches First Evidence-Based Milestone View to Streamline Medical Device Development

Enlil, a leading product lifecycle traceability platform, has unveiled Milestone View, the industry’s first evidence-based system connecting development milestones to regulatory, design, and risk data. The tool enables MedTech teams to replace disconnected timelines with traceable, execution-ready checkpoints, enhancing readiness for FDA eSTAR submissions and reducing late-stage delays.

Transforming Milestone Management:

Traditional milestone tracking often relies on spreadsheets and slide decks, causing misalignment and documentation drift. Milestone View addresses these challenges by linking milestones directly to completed work, approvals, and regulatory evidence, allowing teams to assess progress based on real achievements rather than calendar dates.

Strategic Implications for MedTech:

By unifying product development data into a single platform, Milestone View enhances cross-functional visibility and decision-making. It accelerates FDA submission preparation, reduces audit risks, and provides earlier detection of gaps, helping medical device companies streamline operations while maintaining regulatory compliance.